COVID-19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)-T-cell therapy
Description
More than 3 years have passed since Coronavirus disease 2019 (COVID-19) was declared a global pandemic, yet COVID-19 still severely impacts immunocompromised individuals including those treated with hematopoietic cell transplantation (HCT) and
